This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2hp4
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==Computational design and crystal structure of an enhanced affinity mutant human CD8-alpha-alpha co-receptor== | ==Computational design and crystal structure of an enhanced affinity mutant human CD8-alpha-alpha co-receptor== | ||
<StructureSection load='2hp4' size='340' side='right' caption='[[2hp4]], [[Resolution|resolution]] 2.10Å' scene=''> | <StructureSection load='2hp4' size='340' side='right' caption='[[2hp4]], [[Resolution|resolution]] 2.10Å' scene=''> | ||
| Line 4: | Line 5: | ||
<table><tr><td colspan='2'>[[2hp4]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HP4 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2HP4 FirstGlance]. <br> | <table><tr><td colspan='2'>[[2hp4]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HP4 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2HP4 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2hp4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2hp4 OCA], [http://pdbe.org/2hp4 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=2hp4 RCSB], [http://www.ebi.ac.uk/pdbsum/2hp4 PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2hp4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2hp4 OCA], [http://pdbe.org/2hp4 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=2hp4 RCSB], [http://www.ebi.ac.uk/pdbsum/2hp4 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=2hp4 ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
| Line 14: | Line 15: | ||
Check<jmol> | Check<jmol> | ||
<jmolCheckbox> | <jmolCheckbox> | ||
| - | <scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/hp/2hp4_consurf.spt"</scriptWhenChecked> | + | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/hp/2hp4_consurf.spt"</scriptWhenChecked> |
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | ||
<text>to colour the structure by Evolutionary Conservation</text> | <text>to colour the structure by Evolutionary Conservation</text> | ||
Revision as of 06:55, 27 June 2018
Computational design and crystal structure of an enhanced affinity mutant human CD8-alpha-alpha co-receptor
| |||||||||||
Categories: Human | Boulter, J M | Cole, D K | Gao, G F | Glick, M | Jakobsen, B K | Rizkallah, P J | Cd8 | Co-receptor | Immune system | Immune-suppressor | Immunotherapy | Kd | Protein engineering | Soluble protein

